BioProcess International, August 16, 2019
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system

BioPharma-Reporter.com July 2, 2019
FDA should improve incentives to lower drug costs, says Dyadic CEO

Tailwinds Research Group February 21, 2019
DYAI Looking Increasingly Compelling

NBC News January 31, 2019
The shutdown is over – but not the pain for small businesses

Manufacturing Chemist, January 30, 2019
Is the Production of Biologic Drugs Ready for an Overhaul?

The Washington Post, January 23, 2019
Stuck in shutdown limbo, companies put IPOs on hold

DGIwire January 11, 2019
Looking Beyond Mammals to Microbes for Tomorrow’s Drugs